Loading...
•
Dec 31, 2020
Radnet Q4 2020 Earnings Report
RadNet reported record revenue and adjusted EBITDA in Q4 2020.
Key Takeaways
RadNet's Q4 2020 results were the strongest in the company's history, with revenue increasing by 2.5% and adjusted EBITDA increasing by 8.1% compared to Q4 2019, despite the ongoing impact of COVID-19. The company's aggressive cost management and improved reimbursement contributed to the strong profitability during the quarter. The company had cash balance of $102.0 million.
Revenue increased by 2.5% compared to Q4 2019.
Adjusted EBITDA increased by 8.1% from the fourth quarter of 2019.
Adjusted diluted net income was $0.20 per diluted share compared to $0.19 per diluted share for the same period in 2019.
Mammography volume increased 11.7% from Q4 2019.
Forward Guidance
RadNet expects its business to continue to strengthen as COVID-19 restrictions are lifted and anticipates further benefit from cost reduction measures, increases in reimbursement, and expansion of joint venture initiatives.
Positive Outlook
- Strong recovery of procedural volumes.
- Significant impact from cost reduction programs.
- Potential for accretive tuck-in acquisitions.
- Further benefit from cost reduction measures implemented in 2020.
- Increases in reimbursement from private and capitated payors.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...